secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001628280-26-012552
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks sells Biosecurity segment to Tower Biosecurity for 20% stake
----------------------------------------------------------------------------

- Ginkgo contributes all equity of Ginkgo Biosecurity, LLC (its Biosecurity segment) to Tower Biosecurity.
- In exchange, Ginkgo receives shares representing ~20% of Tower Biosecurity on a fully diluted basis.
- Transaction expected to close in first half of 2026, subject to customary closing conditions.
- Seller is Ginkgo Bioworks, Inc.; parent Ginkgo Bioworks Holdings is party for limited purposes.
- No cash purchase price disclosed; consideration is solely an equity stake in the acquirer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000162828026012552/0001628280-26-012552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000162828026012552/dna-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-012552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer